Lung cancer screening within Brazil's public health care system
Follows lung cancer screening for people aged 50 to 80 in Brazil.
Plain-language title generated from the registry record
Registry title: Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)
Key facts
- Where
- Rio de Janeiro, BrazilSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for current or recent smokers aged 50 to 80 with a heavy smoking history, who are or were in a smoking cessation program, for lung cancer screening.
- Age
- 50 to 80 years
- Sex
- All sexes can join.
- Disease stage
- People without signs or symptoms that suggest lung cancer.
- Earlier treatment
- Must have taken part, or be taking part, in a smoking cessation program.
Main reasons for not taking part
- Claustrophobia or weight above 130 kgs
- Cannot climb 3 stair steps non-stop (36 steps), or has disabling dyspnea
- Symptoms that suggest lung cancer, such as hemoptysis or unexplained weight loss
- Cancer diagnosed less than 10 years ago (except non-melanoma skin cancer)
- Weak immune system, severe psychiatric disease, or earlier lung resection
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 80 years old?
Source: NCT07279948, who can take part
Where in Brazil
- Rio de JaneiroHospital not named in the registryNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- AstraZeneca
- Trial code
- NCT07279948
- Record updated
- 11 September 2026
- Original description
A prospective, longitudinal, single-arm interventional study of lung cancer screening.Read full original descriptionShow less
Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)
A prospective, longitudinal, single-arm interventional study of lung cancer screening.
Inclusion: In order, to be eligible for the study, patients must fulfill all the following inclusion criteria:; Age between ≥50 and ≤80 years; Be a current smoker or have quit 15 years ago or less; Have participated or are currently participating in smoking cessation program; Lifetime smoking exposure equal to or greater than 20 pack-year; Provided signed informed consent (ICF).
Exclusion: In order, to be exclude for the study, patients must at least one of the following exclusion criteria:; Contraindications to the screening examination: (claustrophobic or weighing more than 130 kgs); Inability to climb 3 stair steps non-stop (36 steps); Disabling dyspnea; Symptomatic (with signs and symptoms suspicious of breast cancer lung, namely):; pleuritic chest pain; rapidly progressive dyspnea of recent onset; hemoptysis; unexplained hoarseness, lasting more than 1 month; bone pain; supraclavicular lymphadenopathy or cervical lymphadenopathy persistent; unexplained weight loss of 5% or more of weight in less than 6 months; Previous history of malignant neoplasm (excluding non-melanoma skin cancer) diagnosed less than 10 years before the date of the interview; Patients with diagnostic of severe psychiatric disease; Immunosuppressed by illness or drugs; Subjected to anterior lung resection even when determined due to an etiology other than malignant neoplasia; Person with a serious terminal illness that contraindicates curative lung surgery.